Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation

被引:72
作者
Chartoff, EH
Marck, BT
Matsumoto, AM
Dorsa, DM
Palmiter, RD
机构
[1] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[5] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Ctr Geriatr Res Educ & Clin, Seattle, WA 98195 USA
[6] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA
关键词
D O I
10.1073/pnas.181356498
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Motor stereotypies are abnormally repetitive behaviors that can develop with excessive dopaminergic stimulation and are features of some neurologic disorders. To investigate the mechanisms required for the induction of stereotypy, we examined the responses of dopamine-deficient (DD) mice to increasing doses of the dopamine precursor L-DOPA. DD mice lack the ability to synthesize dopamine (DA) specifically in dopaminergic neurons yet exhibit robust hyperlocomotion relative to wild-type (WT) mice when treated with L-DOPA, which restores striatal DA tissue content to approximate to 10% of WT levels. To further elevate brain DA content in DID mice, we administered the peripheral L-amino acid decarboxylase inhibitor carbidopa along with L-DOPA (C/L-DOPA). When striatal DA levels reached > 50% of WT levels, a transition from hyperlocomotion to intense, focused stereotypy was observed that was correlated with an induction of c-fos mRNA in the ventrolateral and central striatum as well as the somatosensory cortex. WT mice were unaffected by C/L-DOPA treatments. A D1, but not a D2, receptor antagonist attenuated both the C/L-DOPA-induced stereotypy and the c-fos induction. Consistent with these results, stereotypy could be induced in DD mice by a DI, but not by a D2, receptor agonist, with neither agonist inducing stereotypy in WT mice. Intrastriatal injection of a D1 receptor antagonist ameliorated the stereotypy and c-fos induction by C/L-DOPA. These results indicate that activation of D1 receptors on a specific population of striatal neurons is required for the induction of stereotypy in DD mice.
引用
收藏
页码:10451 / 10456
页数:6
相关论文
共 37 条
  • [1] STRIATAL D1 DOPAMINE RECEPTOR DISTRIBUTION FOLLOWING CHEMICAL LESION OF THE NIGROSTRIATAL PATHWAY
    ARIANO, MA
    [J]. BRAIN RESEARCH, 1988, 443 (1-2) : 204 - 214
  • [2] BREESE GR, 1987, J PHARMACOL EXP THER, V240, P167
  • [3] BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343
  • [4] BREESE GR, 1985, J PHARMACOL EXP THER, V234, P447
  • [5] A measure of striatal function predicts motor stereotypy
    Canales, JJ
    Graybiel, AM
    [J]. NATURE NEUROSCIENCE, 2000, 3 (04) : 377 - 383
  • [6] Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
    Carlsson, A
    Waters, N
    Holm-Waters, S
    Tedroff, J
    Nilsson, M
    Carlsson, ML
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 : 237 - 260
  • [7] The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice
    Chen, JF
    Moratalla, R
    Impagnatiello, F
    Grandy, DK
    Cuellar, B
    Rubinstein, M
    Beilstein, MA
    Hackett, E
    Fink, JS
    Low, MJ
    Ongini, E
    Schwarzschild, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1970 - 1975
  • [8] Maintenance of amphetamine induced stereotypy and locomotion requires ongoing dopamine receptor activation
    Conti, LH
    Segal, DS
    Kuczenski, R
    [J]. PSYCHOPHARMACOLOGY, 1997, 130 (02) : 183 - 188
  • [9] AMPHETAMINE RESPONSE IN RAT AFTER DOPAMINE NEURON DESTRUCTION
    CREESE, I
    IVERSEN, SD
    [J]. NATURE-NEW BIOLOGY, 1972, 238 (86): : 247 - &
  • [10] BLOCKAGE OF AMPHETAMINE INDUCED MOTOR STIMULATION AND STEREOTYPY IN ADULT RAT FOLLOWING NEONATAL TREATMENT WITH 6-HYDROXYDOPAMINE
    CREESE, I
    IVERSEN, SD
    [J]. BRAIN RESEARCH, 1973, 55 (02) : 369 - 382